enGene Holdings Inc. (ENGN)
NASDAQ: ENGN · IEX Real-Time Price · USD
8.99
+0.04 (0.45%)
At close: Jul 19, 2024, 4:30 PM
9.01
+0.02 (0.22%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
enGene Holdings Market Cap
enGene Holdings has a market cap or net worth of $397.05 million as of July 22, 2024. Its market cap has increased by 133.42% in one year.
Market Cap
397.05M
Enterprise Value
156.85M
1-Year Change
133.42%
Ranking
Category
Stock Price
$8.99
Market Cap Chart
Since December 10, 2021, enGene Holdings's market cap has increased from $124.90M to $397.05M, an increase of 217.90%. That is a compound annual growth rate of 55.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 397.10M | 85.47% |
| Dec 29, 2023 | 214.10M | 31.11% |
| Dec 30, 2022 | 163.30M | 30.12% |
| Dec 31, 2021 | 125.50M | 0.48% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cerus | 406.76M |
| Alto Neuroscience | 402.99M |
| Precigen | 401.35M |
| AxoGen | 398.59M |
| Lyell Immunopharma | 397.70M |
| Organogenesis Holdings | 384.46M |
| Revance Therapeutics | 379.67M |
| Sight Sciences | 378.65M |